Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Q: What does CUSIP 16385C104 represent in this 13F holders report?

CUSIP 16385C104 is the security identifier for CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares used to aggregate holder disclosures.

Q: How many institutions held CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares in Q4 2023?

16 institutional investors reported CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 16385C104

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Ordinary Shares / American Depositary Shares
Total 13F shares: 2,813,782
Total 13F value: $1,434,861
Share change: +283,206
SEC-reported price per share: $0.51
Number of holders: 16
Value change: +$143,796
Number of buys: 8
Number of sells: 3
Shares outstanding: 412,914,375

Security key

16385C104

Report period

Q4 2023

Institutions

Top holders

CMMB full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Chemomab Therapeutics Ltd. SEC filings Chemomab Therapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 16385C104

Newer quarter: Q3 2025

Recent filing periods:

Q3 2025

Ownership snapshot

Top reported holders of CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

OrbiMed Israel GP Ltd.

Disclosed value leader

OrbiMed Israel GP Ltd.

Comparable rows

0/15

Latest evidence

30 Sep 2023

3/4/5 13F Highest disclosed value: $10,108,146 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

OrbiMed Israel GP Ltd. has the largest disclosed position value at $10.11M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens OrbiMed Israel GP Ltd.'s linked filing trail.

Disclosed position value Top 5

OrbiMed Israel GP Ltd. $10.11M

ORBIMED ADVISORS LLC $2.67M

Novo Holdings A/S $1.8M

Soleus Capital Management, L.P. $645.9K

Ikarian Capital, LLC $191K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
OrbiMed Israel GP Ltd.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$10,108,146 2,241,274 shares	—	03 Jan 2023
ORBIMED ADVISORS LLC	13F Company 13F	— mixed-class rows	$2,671,325 3,166,062 shares mixed-class rows	—	30 Sep 2023
Novo Holdings A/S	13F Company 13F	— denominator unverified	$1,798,410 2,497,791 shares	—	30 Sep 2023
Soleus Capital Management, L.P.	13F Company 13F	— denominator unverified	$645,864 897,657 shares	—	30 Sep 2023
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$190,986 213,392 shares	—	30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— mixed-class rows	$160,432 220,070 shares mixed-class rows	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,813,782

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend